<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Greco SH</submitter><funding>S.H.G.</funding><funding>G.M.</funding><funding>NCI NIH HHS</funding><funding>U.S. National Institutes of Health</funding><pagination>185-94</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6608084</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>100(1)</volume><pubmed_abstract>Regulation of Toll-like receptor responses is critical for limiting tissue injury and autoimmunity in both sepsis and sterile inflammation. We found that Mincle, a C-type lectin receptor, regulates proinflammatory Toll-like receptor 4 signaling. Specifically, Mincle ligation diminishes Toll-like receptor 4-mediated inflammation, whereas Mincle deletion or knockdown results in marked hyperresponsiveness to lipopolysaccharide in vitro, as well as overwhelming lipopolysaccharide-mediated inflammation in vivo. Mechanistically, Mincle deletion does not up-regulate Toll-like receptor 4 expression or reduce interleukin 10 production after Toll-like receptor 4 ligation; however, Mincle deletion decreases production of the p38 mitogen-activated protein kinase-dependent inhibitory intermediate suppressor of cytokine signaling 1, A20, and ABIN3 and increases expression of the Toll-like receptor 4 coreceptor CD14. Blockade of CD14 mitigates the increased sensitivity of Mincle(-/-) leukocytes to Toll-like receptor 4 ligation. Collectively, we describe a major role for Mincle in suppressing Toll-like receptor 4 responses and implicate its importance in nonmycobacterial models of inflammation.</pubmed_abstract><journal>Journal of leukocyte biology</journal><pubmed_title>Mincle suppresses Toll-like receptor 4 activation.</pubmed_title><pmcid>PMC6608084</pmcid><funding_grant_id>R21 CA155649</funding_grant_id><funding_grant_id>CA168611</funding_grant_id><funding_grant_id>R01 CA168611</funding_grant_id><funding_grant_id>CA155649</funding_grant_id><pubmed_authors>Ochi A</pubmed_authors><pubmed_authors>Miller G</pubmed_authors><pubmed_authors>Daley D</pubmed_authors><pubmed_authors>Mani VR</pubmed_authors><pubmed_authors>Pachter HL</pubmed_authors><pubmed_authors>Seifert L</pubmed_authors><pubmed_authors>Vahle AK</pubmed_authors><pubmed_authors>Barilla R</pubmed_authors><pubmed_authors>Batel J</pubmed_authors><pubmed_authors>Greco SH</pubmed_authors><pubmed_authors>Mahmood SK</pubmed_authors><pubmed_authors>Deutsch M</pubmed_authors><pubmed_authors>Hundeyin M</pubmed_authors><pubmed_authors>Torres-Hernandez A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mincle suppresses Toll-like receptor 4 activation.</name><description>Regulation of Toll-like receptor responses is critical for limiting tissue injury and autoimmunity in both sepsis and sterile inflammation. We found that Mincle, a C-type lectin receptor, regulates proinflammatory Toll-like receptor 4 signaling. Specifically, Mincle ligation diminishes Toll-like receptor 4-mediated inflammation, whereas Mincle deletion or knockdown results in marked hyperresponsiveness to lipopolysaccharide in vitro, as well as overwhelming lipopolysaccharide-mediated inflammation in vivo. Mechanistically, Mincle deletion does not up-regulate Toll-like receptor 4 expression or reduce interleukin 10 production after Toll-like receptor 4 ligation; however, Mincle deletion decreases production of the p38 mitogen-activated protein kinase-dependent inhibitory intermediate suppressor of cytokine signaling 1, A20, and ABIN3 and increases expression of the Toll-like receptor 4 coreceptor CD14. Blockade of CD14 mitigates the increased sensitivity of Mincle(-/-) leukocytes to Toll-like receptor 4 ligation. Collectively, we describe a major role for Mincle in suppressing Toll-like receptor 4 responses and implicate its importance in nonmycobacterial models of inflammation.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jul</publication><modification>2025-04-22T20:35:10.261Z</modification><creation>2019-07-25T07:03:25Z</creation></dates><accession>S-EPMC6608084</accession><cross_references><pubmed>26747838</pubmed><doi>10.1189/jlb.3a0515-185r</doi><doi>10.1189/jlb.3A0515-185R</doi></cross_references></HashMap>